Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival

Paul C McDonald1, Arusha Oloumi, Julia Mills

  • 1Department of Cancer Genetics, BC Cancer Research Centre, British Columbia Cancer Agency, Vancouver, BC, Canada.

Cancer Research
|March 15, 2008
PubMed

Insights

Rictor binds to integrin-linked kinase (ILK), regulating Akt phosphorylation and promoting cancer cell survival. This interaction is crucial for ILK

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Signal Transduction

Background:

  • Integrin-linked kinase (ILK) is a key regulator of cellular processes.
  • Rictor is a component of mTORC2, involved in Akt phosphorylation.
  • ILK and rictor share overlapping functions in cytoskeletal dynamics and cell signaling.

Purpose of the Study:

  • To identify novel ILK-binding proteins.
  • To investigate the functional interaction between ILK and rictor.
  • To elucidate the role of the ILK-rictor complex in cancer cell signaling and survival.

Main Methods:

  • Unbiased proteomic screening
  • Coimmunoprecipitation assays
  • Yeast two-hybrid assays
  • siRNA-mediated gene depletion
  • Western blotting for Akt phosphorylation

Main Results:

  • Rictor was identified as a direct ILK-binding protein.
  • ILK and rictor colocalize in cancer cells and interact directly.
  • Depletion of ILK or rictor inhibits Akt Ser(473) phosphorylation and induces apoptosis.
  • Rictor, not mTOR, regulates Akt phosphorylation within the ILK complex.

Conclusions:

  • Rictor is a critical regulator of ILK-mediated Akt phosphorylation.
  • The ILK-rictor interaction is essential for cancer cell survival.
  • Targeting the ILK-rictor complex may offer therapeutic strategies for cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...